Goldbug100 - Pharmalink International Limited – Results For H1 ended 30 June 2011 Net profit + 25.30%

5 August 2011 - Consolidated Financial Results for the Half Year Ended 30 June 2011

. Sales increased 03.00% to US$7,008,496 (2010 US$6,990,345)

. Net profit increased 25.30% to US$2,743,096 (2010) US$2,189.007)

. Net profit margin increased to 39.10% from (2010 31.30%)

. Total assets increased 36.30% to US$13,694,726 (2010 US$10,049,085)

. Net asset value per share increased 34.70% to $US$8.23 (2010 US$6.11)

. Cash and deposits increased 94.00% to US$4,842,150 (2009 US$2,496,339) The Company has not debt

. Net profit per share was US$1.92 (2010 US$1.53) an increase of 25.50%

. Interim dividend US$0.50 to be paid to shareholder in September 2011 (2010 US$0.50)

The shares are traded over the counter in Hong Kong.

original shareholders acquired their holding in Pharmalink having been shareholders in Special Assets Limited (HK.B12179)
.

Company´s websites www.lyprinol.com and www.OmegaXL.com - Email skwok@sal.com.hk

Goldbug100 - Pharmalink International Limited – Results For the year ended 31 December 2010

12 April 2011 - Consolidated Financial Results for the Full Year Ended 31 December 2010

. Sales increased 60.00% to US$13,788,148 (2009 US$8,619,843)

. Net profit increased 155.70% to US$4,769,961 (2009) US$1,865,189)

. Net profit margin increased to 34.60% (2009 21.60%)

. Total assets increased 46.30% to US$12,507,627 (2009 US$8,551,381)

. Net asset value per share increased 29.50% to $US$6.31 (2009 US$4.87)

. Cash and deposits increased 44.60% to US$3,588,675 (2009 US$2,482,712) The Company has not debt

. Net profit per share was US$3.34 (2009 US$1.39) an increase of 156.90%

. Final dividend US$1.20 to be paid to shareholder on 31 May 2011 making a total for the year of $1.70

Sales increased in the USA Great Health Works (GHW) by 137.80% - Sales to European Distributors increased by 34.20% - Poland 1,176.25%

The shares are traded over the counter in Hong Kong., The highest price paid was US$22.95 and the lowest US$5.50 – the last trade US$22.95 13 December 2010

original shareholders acquired their holding in Pharmalink having been shareholders in Special Assets Limited (HK.B12179)

Company´s websites www.lyprinol.com and www.OmegaXL.com - Email skwok@sal.com.hk